Homeostasis and self-tolerance in the immune system: turning lymphocytes off.
暂无分享,去创建一个
[1] David Gray,et al. Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.
[2] T. Mak,et al. Normal responsiveness of CTLA-4-deficient anti-viral cytotoxic T cells. , 1998, Journal of immunology.
[3] R. Schwartz,et al. A cell culture model for T lymphocyte clonal anergy. , 1990, Science.
[4] J. Sprent,et al. Lymphocyte life-span and memory. , 1994, Science.
[5] R. Welsh,et al. Role of apoptosis in the regulation of virus‐induced T cell responses, immune suppression, and memory , 1995, Journal of cellular biochemistry.
[6] P. Matzinger. Tolerance, danger, and the extended family. , 1994, Annual review of immunology.
[7] S. Nagata,et al. Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.
[8] P. Allen,et al. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells , 1993, Nature.
[9] A. Feller,et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.
[10] C. Janeway,et al. Innate Immunity: The Virtues of a Nonclonal System of Recognition , 1997, Cell.
[11] H. Pircher,et al. Ablation of “tolerance” and induction of diabetes by virus infection in viral antigen transgenic mice , 1991, Cell.
[12] S. Wahl,et al. Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.
[13] S. Smith‐Gill,et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice , 1988, Nature.
[14] A. Abbas,et al. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. , 1994, Immunity.
[15] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[16] J. Kinoshita. Women Fight Uphill Battle for Equity , 1996, Science.
[17] T. Brocker. Survival of Mature CD4 T Lymphocytes Is Dependent on Major Histocompatibility Complex Class II–expressing Dendritic Cells , 1997, The Journal of experimental medicine.
[18] H. Griesser,et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.
[19] K. Rajewsky,et al. Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.
[20] K. Rajewsky,et al. In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.
[21] J. Todd,et al. Mapping of the IDDM Locus Idd3 to a 0.35-cM Interval Containing the Interleukin-2 Gene , 1997, Diabetes.
[22] Mark M. Davis,et al. CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells , 1995, Nature.
[23] R. Schwartz. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy , 1992, Cell.
[24] Warren Strober,et al. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome , 1995, Cell.
[25] A. Khoruts,et al. The anatomy of T-cell activation and tolerance. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[26] F. Alt,et al. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. , 1997, Journal of immunology.
[27] A. Abbas,et al. Role of Fas-mediated cell death in the regulation of immune responses. , 1996, Current opinion in immunology.
[28] K. Rajewsky,et al. Bcl-2 increases memory B cell recruitment but does not perturb selection in germinal centers. , 1994, Immunity.
[29] J. Bluestone,et al. CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.
[30] S. Cory. Regulation of lymphocyte survival by the bcl-2 gene family. , 1995, Annual review of immunology.
[31] P. Linsley,et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways , 1996, Nature.
[32] M. Lenardo. Fas and the art of lymphocyte maintenance , 1996, The Journal of experimental medicine.
[33] F. Powrie,et al. T cells in inflammatory bowel disease: protective and pathogenic roles. , 1995, Immunity.
[34] D. Peterson,et al. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. , 1998, Immunity.
[35] John A Todd,et al. Genetic Analysis of Autoimmune Disease , 1996, Cell.
[36] R. Locksley,et al. The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.
[37] A. Fischer,et al. Natural and engineered disorders of lymphocyte development. , 1998, Science.
[38] T. Sullivan,et al. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. , 1997, Immunity.
[39] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[40] A. Khoruts,et al. A Natural Immunological Adjuvant Enhances T Cell Clonal Expansion through a CD28-dependent, Interleukin (IL)-2–independent Mechanism , 1998, The Journal of experimental medicine.
[41] T. Strom,et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. , 1997, Immunity.
[42] T. Sullivan,et al. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo. , 1996, International immunology.
[43] J Bajorath,et al. Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.